Filing Details
- Accession Number:
- 0001437749-25-022551
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-10 20:56:09
- Reporting Period:
- 2025-07-08
- Filing Date:
- 2025-07-10
- Accepted Time:
- 2025-07-10 20:56:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401667 | Puma Biotechnology Inc. | PBYI | Pharmaceutical Preparations (2834) | 770683487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1758507 | F Maximo Nougues | C/O Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles CA 90024 | Chief Financial Officer | No | Yes | No | No |
Transaction Summary
| Sold: | 9,522 shares | Avg. Price: $3.53 | Total Value: $33,649.10 |
| Number of Shares After Transactions: | 204,229 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-08 | 5,587 | $3.53 | 208,164 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-09 | 3,935 | $3.54 | 204,229 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Adoption date of referenced 10b5-1(c) plan is: 12-14-2020
Billionaire Hedge Funds
